跳到主要內容

Boudreaux Gail 的 Form 4 申報

Elevance Health, Inc.ELV,2025/7/18 申報

申報編號
0001287920-25-000005
申報時間
2025/7/18
交易日
2025/7/18
申報延遲
當天
10b5-1 計畫
沒有勾選

這份申報列了 3 筆非衍生性交易。公開市場買進合計 $243.9 萬。交易當天就申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Boudreaux GailCIK 0001287920董事、高階主管(總裁、執行長)

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2025/7/18Common StockP買進取得+2,334$286.07F1+$667,687.38144,854直接
2025/7/18Common StockP買進取得+5,116$287.12F2+$1,468,905.92149,970直接
2025/7/18Common StockP買進取得+1,050$287.96F3+$302,358151,020直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F1

This transaction was executed in multiple purchases at prices ranging from $285.50 to $286.43. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

表 I 有 1 筆交易的價格引用這則附註。

F2

This transaction was executed in multiple purchases at prices ranging from $286.70 to $287.69. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

表 I 有 1 筆交易的價格引用這則附註。

F3

This transaction was executed in multiple purchases at prices ranging from $287.72 to $288.14. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)